Article
Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.
The Journal of pathology - 1 Oct 2004
Gonzalez Michael A, Tachibana Kiku-E K, Chin Suet-Feung, Callagy Grace, Madine Mark A, Vowler Sarah L, Pinder Sarah E, Laskey Ronald A, Coleman Nicholas
Abstract excerpt
Geminin inhibits DNA replication by preventing Cdt1 from loading minichromosome maintenance (MCM) proteins onto DNA. The present study has investigated whether the frequency of geminin expression predicts clinical outcome in breast cancer. Immunohistochemistry was used first to examine geminin expression in normal and malignant breast tissue (n = 67). Correlations with cell-cycle parameters, pathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
